Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle

Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets and Virt Gard Tablets because product labels do not reflect the cor…

Recall #: F-1932-2018
Affected scope: 2209 Bottles
Initiated: August 3, 2018

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Food →

View my saved recalls

Virtus Pharmaceuticals LLC. recalled Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bo… - a low-severity action.

Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bo… was recalled by Virtus Pharmaceuticals LLC. in September 12, 2018. Reason: Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets …. Check the official notice for the remedy. Verify recall #F-1932-2018 with the FDA Food before acting.

The recall

Virtus Pharmaceuticals LLC. issued this low-severity FDA Food recall-Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets ….

Low
severity level: Class III
classification: September 12, 2018
reported

Sourced from official FDA Food enforcement records. Verify recall #F-1932-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle

Reason for recall

Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets and Virt Gard Tablets because product labels do not reflect the correct amount of Dietary Folate Equivalents (DFEs) calculated based on the product formulation.

Recall Profile

Structured summary of the FDA Food recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Terminated
Recall number	F-1932-2018
Date reported	September 12, 2018
Date initiated	August 3, 2018
Recalling firm	Virtus Pharmaceuticals LLC.
Firm location	Newtown, PA
Affected scope	2209 Bottles
Distribution	Virt Nate: Arizona, Colorado, Illinois, Indiana, Michigan, Minnesota, Missouri, Mississippi, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Vermont and Wisconsin. Virt Gard: Arizona, California, Colorado, Fl…

Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (F-1932-2018) and product description against the item you own. Search the archive
Confirm the current status with FDA Food before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle. Recalled by Virtus Pharmaceuticals LLC.. Units affected: 2209 Bottles.

Why was this product recalled? ▼

Which agency issued this recall? ▼

This recall was issued by the FDA Food on September 12, 2018. Severity: Low. Recall number: F-1932-2018.

Where was the recalled product distributed? ▼

Distribution: Virt Nate: Arizona, Colorado, Illinois, Indiana, Michigan, Minnesota, Missouri, Mississippi, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Vermont and Wisconsin. Virt Gard: Arizona, California, Colorado, Florida, Georgia, Iowa, Illinois, Kentucky, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Virginia and West Virginia..

What are the health risks of consuming a recalled food product? ▼

Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.

Nationwide recalls with similar severity or category timing

Food and dietary-supplement notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

AutoDELFIA Neonatal immunoreactive trypsi… 2018-09-12 Zenlens Toric-Gas Permeable Contact lense… 2018-09-12 Zen RC Toric-Gas permeable contact lenses… 2018-09-12 Argatroban Injection, 250 mg/2.5 mL (100 … 2018-09-19

Similar Children & Baby Products · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Ethosuximide Capsules, USP, 250 mg, 100 c… 2018-09-12 Diltiazem HCl Extended-Release Capsules, … 2018-09-19 Diltiazem HCl Extended-Release Capsules, … 2018-09-19 Compulsin, Homeopathic (OTC Medicine), 2 … 2018-09-19

Compare this recall with CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per … → · All Children & Baby Products recalls

This recall: FDA Food, reported September 12, 2018. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026